World's Best Scientists 2026 revealed!
Cancer Biology and Therapy
H-index 20

Cancer Biology and Therapy

1538-4047

Published by: Taylor & Francis

https://www.tandfonline.com/loi/kcbt20

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1721 47 54 15

Additional Metrics

Number of Best Scientists*: 107
Documents by Best Scientists*: 102
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 134
SCIMAGO SJR: 1.202
Impact Factor: 4.6

Overview

Top Research Topics at Cancer Biology & Therapy?

The journal investigates areas of study like Cancer research, Internal medicine, Apoptosis, Cancer and Molecular biology. The studies on Cancer research discussed can also contribute to research in the domains of Cell culture, Cell growth, Cancer cell, Immunology and Pathology. Immunohistochemistry is a focus of the presented Pathology works and it dives deep in Immunohistochemistry.

The concepts on Internal medicine presented in the journal can also apply to other research fields, including Endocrinology and Oncology. The in-depth study on Oncology also explores topics in the intersecting field of Colorectal cancer. Downregulation and upregulation, Pharmacology and Cell biology are some topics wherein Apoptosis research discussed in it have an impact.

The majority of Cell biology studies are focused on the issues of Signal transduction. Metastasis and Carcinogenesis are among the areas of Cancer tackled. While work presented in Cancer Biology & Therapy provided substantial information on Molecular biology, it also covered topics in Transfection and In vivo.

  • Cancer research (46.92%)
  • Internal medicine (19.51%)
  • Apoptosis (17.05%)

What are the most cited papers published in the journal?

  • Overview of cell death signaling pathways (1026 citations)
  • The PIK3CA gene is mutated with high frequency in human breast cancers (572 citations)
  • Identification of fibroblast heterogeneity in the tumor microenvironment (511 citations)

Research areas of the most cited articles at Cancer Biology & Therapy:

The published articles focus largely on the fields of Cancer research, Cell biology, Cancer, Apoptosis and Molecular biology. The published papers focus on Cancer research but sometimes tackle the closely related topic of Pathology which is concerned with Metastasis. While Cancer is the focus of the most cited publications, it also provides insights into the studies of Immunology and Oncology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The main points discussed in the journal deals with Cancer research, Apoptosis, Cancer, Cell growth and Cancer cell. Gene knockdown, Downregulation and upregulation, Signal transduction, microRNA and Lung cancer are some topics wherein Cancer research research discussed in the journal have an impact. While Apoptosis is the focus of Cancer Biology & Therapy, it also provided insights into the studies of Chemotherapy, PKM2, Cell biology, Gene silencing and Colorectal cancer.

The journal focuses on Cancer research as part of the broader topic of Internal medicine. Cancer Biology & Therapy addresses concerns in Cell growth which are intertwined with other disciplines, such as Carcinogenesis, Gene and Glioma. While it focused on Cancer cell, it was also able to explore topics like Histone H3, Histone methyltransferase, THP1 cell line, Myeloid leukemia and EZH2.

The most cited articles from the last journal are:

  • Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism (4 citations)
  • YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2. (3 citations)
  • Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Biology & Therapy (based on the number of publications) are:

  • William D. Figg (86 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • Wafik S. El-Deiry (84 papers) absent at the last edition,
  • Paul Dent (70 papers) absent at the last edition,
  • Steven Grant (36 papers) absent at the last edition,
  • Daiming Fan (27 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Biology & Therapy (based on the number of publications) are:

  • University of Pennsylvania (228 papers) absent at the last edition,
  • Johns Hopkins University (162 papers) absent at the last edition,
  • University of Texas MD Anderson Cancer Center (145 papers) absent at the last edition,
  • National Institutes of Health (109 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • Harvard University (77 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.04% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 4.17% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.58% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.58% of all publications and 66.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Contributions from Related Fields

In addition to the fields directly involved in cancer biology and therapy, it is important to note that research from related fields also contributes significantly to the advancement of oncological knowledge. For instance, nursing plays a pivotal role in cancer management. Specifically, research and advancements in Licensed Practical Nurse (LPN) programs have introduced new perspectives in areas such as patient care, chemotherapy administration, and patient education, thus significantly enhancing the broader field of Cancer Biology & Therapy. One such notable contribution comes from lpn programs in florida. These programs have produced graduates who bring practical, hands-on expertise to the cancer care team, providing patients with optimal care while also participating in critical research. The lateral collaboration between these diverse fields continues to be a driving force in our collective effort to understand, prevent, and ultimately overcome cancer. It is thus crucial to acknowledge these interconnected contributions and ensure that findings and advancements from such programs are seamlessly integrated into the broader cancer research discourse for the benefit of all stakeholders involved.

Top Publications

  • Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues

    Alex M. Li;Amélie Boichard;Razelle Kurzrock

    (2020)
    40 Citations
  • Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor

    (2022)
    34 Citations
  • Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer.

    Branislava Janic;Stephen L Brown;Ryan Neff;Fangchao Liu

    (2021)
    34 Citations
  • Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review.

    Stephen J. O’Brien;Campbell Bishop;Jacob Hallion;Casey Fiechter

    (2020)
    33 Citations
  • Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells

    (2022)
    33 Citations
  • Lutetium-177-PSMA-617: A Vision of the Future

    (2022)
    32 Citations
  • Interleukin-2, Ipilimumab, and Anti-PD-1: Clinical Management and the Evolving Role of Immunotherapy for the Treatment of Patients With Metastatic Melanoma

    Tasha Hughes;Matthew Klairmont;William H Sharfman;Howard L Kaufman

    (2021)
    30 Citations
  • BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment

    (2020)
    25 Citations
  • Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

    Rebecca C Arend;Amy Jackson-Fisher;Ira A Jacobs;Jeffrey Chou

    (2021)
    23 Citations
  • Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas

    Angela Santoro;Pantaleo Bufo;Giuseppe Russo;Simona Cagiano

    (2020)
    22 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not ready to commit to a full medical degree, there are several alternative pathways worth considering. Programs like the 6 months lpn program offer a fast and affordable route to becoming a Licensed Practical Nurse, allowing students to enter the workforce quickly while gaining essential clinical skills.

For individuals seeking advanced education, pursuing an online doctorate in nursing can open doors to leadership roles in healthcare, research, and education. These programs provide flexibility for working professionals looking to elevate their careers without relocating.

Besides nursing and direct patient care, administrative roles are vital in healthcare systems. Studying at the best online medical billing and coding schools enables students to develop expertise in managing healthcare data and insurance processes, skills critical to the operational backbone of medical facilities.

Additionally, a foundation in the life sciences can lead to diverse opportunities. Exploring biology major careers reveals paths ranging from research and biotechnology to public health and conservation, offering options beyond traditional medical roles.

Best Scientists Contributing to This Journal

Recently Published Articles